AU2003259547A1 - Ezetimibe polymorphs - Google Patents

Ezetimibe polymorphs

Info

Publication number
AU2003259547A1
AU2003259547A1 AU2003259547A AU2003259547A AU2003259547A1 AU 2003259547 A1 AU2003259547 A1 AU 2003259547A1 AU 2003259547 A AU2003259547 A AU 2003259547A AU 2003259547 A AU2003259547 A AU 2003259547A AU 2003259547 A1 AU2003259547 A1 AU 2003259547A1
Authority
AU
Australia
Prior art keywords
ezetimibe
polymorphs
ezetimibe polymorphs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003259547A
Inventor
Dasari Muralidhara Reddy
Bandi Parthasaradhi Reddy
Rapolu Raji Reddy
Kura Rathnakar Reddy
Kesireddy Subash Chander Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of AU2003259547A1 publication Critical patent/AU2003259547A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
AU2003259547A 2003-07-31 2003-07-31 Ezetimibe polymorphs Abandoned AU2003259547A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000258 WO2005009955A1 (en) 2003-07-31 2003-07-31 Ezetimibe polymorphs

Publications (1)

Publication Number Publication Date
AU2003259547A1 true AU2003259547A1 (en) 2005-02-14

Family

ID=34090468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259547A Abandoned AU2003259547A1 (en) 2003-07-31 2003-07-31 Ezetimibe polymorphs

Country Status (2)

Country Link
AU (1) AU2003259547A1 (en)
WO (1) WO2005009955A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007526251A (en) * 2004-12-03 2007-09-13 テバ ファーマシューティカル インダストリーズ リミティド Ezetimibe polymorph
TW200738676A (en) 2005-06-20 2007-10-16 Schering Corp Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
EP1741427A1 (en) 2005-07-06 2007-01-10 KRKA, D.D., Novo Mesto Pharmaceutical composition comprising simvastatin and ezetimibe
EP2012649B1 (en) * 2006-05-03 2017-07-12 Cook Medical Technologies LLC Endoscope rotational and positioning apparatus
WO2008032338A2 (en) * 2006-09-11 2008-03-20 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe and its intermediates
EP1939174A1 (en) * 2006-12-21 2008-07-02 LEK Pharmaceuticals D.D. Inclusion complex of ezetimibe and a cyclodextrin and processes in the preparation thereof
EP1953140A1 (en) * 2007-01-24 2008-08-06 Krka Process for the preparation of ezetimibe and derivatives thereof
WO2008089984A2 (en) 2007-01-24 2008-07-31 Krka Process for the preparation of ezetimibe and derivatives thereof
EP2204170A1 (en) 2008-12-01 2010-07-07 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising ezetimibe and simvastatin
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
EP2368543A1 (en) 2010-03-25 2011-09-28 KRKA, tovarna zdravil, d.d., Novo mesto Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe
HUP1000327A2 (en) 2010-06-18 2012-01-30 Druggability Technologies Ip Holdco Jersey Ltd Composition containing nanostructured ezetibime and process for it's preparation
CN105017119A (en) * 2015-07-23 2015-11-04 青岛蓝盛洋医药生物科技有限责任公司 Lipid-lowering drug ezetimibe compound
CN104983713A (en) * 2015-07-23 2015-10-21 青岛蓝盛洋医药生物科技有限责任公司 Ezetimibe composition capsule for treating cardio-cerebral vascular system diseases
CN104940153A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Ezetimibe composition tablet as medicine for treating hyperlipidemia
US10905736B2 (en) * 2016-09-28 2021-02-02 The Regents Of The University Of California Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism
CN106892851A (en) * 2017-03-09 2017-06-27 上海华源医药科技发展有限公司 A kind of new method for preparing Ezetimibe crystal formation I

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
AU7472896A (en) * 1995-11-02 1997-05-22 Schering Corporation Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-({phenyl or 4-fluorophenyl})-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinon
US5739321A (en) * 1996-05-31 1998-04-14 Schering Corporation 3-hydroxy γ-lactone based enantionselective synthesis of azetidinones
EP1135365A1 (en) * 1998-12-04 2001-09-26 American Home Products Corporation 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction

Also Published As

Publication number Publication date
WO2005009955A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
AU2003291579A1 (en) Yield improvement
AU2003902255A0 (en) Motor
AU2003272930A1 (en) Footwere
GB0319935D0 (en) Polymorphs
AU2003259547A1 (en) Ezetimibe polymorphs
AU2003209667A1 (en) Bicalutamide polymorphs
AU2003274573A1 (en) Deburrer
AU2003901223A0 (en) Continuous centrifuge
GB0315629D0 (en) New uses for antibiotic
AU2003903629A0 (en) New compound
AU2003903205A0 (en) New compound
AU2003241210A1 (en) Videocomputer
AU2003900207A0 (en) New compounds
AU2003904509A0 (en) Novel Compounds
AU2003901012A0 (en) Novel compounds
AU2003904500A0 (en) Novel compounds II
AU2003904501A0 (en) Novel compounds III
AU2004264757B2 (en) Osteogenesis promoter
AU2003100942A4 (en) Energenz
AU2003100378A4 (en) Scootermansydney
AU2003100198A4 (en) Colourband Browbands
AU2003100006A4 (en) Adcaster
AU2003100325A4 (en) Freez-A-Cube
AU2003903928A0 (en) New compounds
AU2003901804A0 (en) New compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase